Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-126238
Filing Date
2026-03-26
Accepted
2026-03-26 16:09:59
Documents
101
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rkda-20251231.htm   iXBRL 10-K 3439662
2 EX-23.1 rkda-ex23_1.htm EX-23.1 5312
3 EX-31.1 rkda-ex31_1.htm EX-31.1 17657
4 EX-31.2 rkda-ex31_2.htm EX-31.2 17653
5 EX-32.1 rkda-ex32_1.htm EX-32.1 8580
6 EX-32.2 rkda-ex32_2.htm EX-32.2 8583
  Complete submission text file 0001193125-26-126238.txt   16040421

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20251231.xsd EX-101.SCH 2613695
105 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20251231_htm.xml XML 3155357
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37383 | Film No.: 26798276
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)